MindImmune Therapeutics, Inc. Employee Directory
Biotechnology ResearchRhode Island, United States11-50 Employees
MindImmune Therapeutics, Inc. is a biotechnology research company focused on the inflammatory drivers of Alzheimer's disease and other neurodegenerative disorders. Its scientists seek to unlock therapeutic opportunities by adjusting immune system activity to treat brain disease. Positioned in the biopharmaceutical sector, MindImmune pursues immune-based strategies to address neurodegeneration. The company is headquartered in Providence, Rhode Island. Its work targets the development of immune-modulating therapies for Alzheimer's and related neurodegenerative conditions, with potential applications for researchers and organizations pursuing novel brain-disease treatments. In 2025, MindImmune strengthened its leadership by appointing Thomas Prod’homme as Vice President of Preclinical Development, and he was introduced as a co-founder and as President and CEO, signaling an important step in the company’s growth.